The report identifies opportunities in optimizing Basal Cell Carcinoma clinical trials through strategic location selection, understanding enrollment trends, and evaluating trial success rates. It ...

The report reveals opportunities for strategic investments in Herpes Zoster clinical trials, highlights key global trial locations, and assesses trial success rates. It offers insights into trial ...

Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...

A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

Ultraviolet light therapy may help reduce inflammation and disease severity in people with MS, according to data from a small ...

Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook the U.K.’s AstraZeneca as the top clinical trial sponsor in ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

Columbia University received a major grant renewal from the National Institutes of Health to fund its comprehensive cancer ...

Objectives Disease activity assessment is important for Crohn’s disease (CD) management, since it involves the initial and subsequent therapeutic schedule. The purpose of this study is to identify a ...

We are conducting a two-part exploration of Benign Prostatic Hyperplasia (BPH), reviewing both the historical and the forward ...

Ultragenyx reported third quarter revenue of $160 million, with Crysvita contributing $112 million (North America $57 million, Latin America and Turkey $47 million, Europe $8 million). Dojolvi ...

Bender announced a raised full-year 2025 revenue guidance, citing "improved visibility into year-end," with a new range of "$145 million to $150 million for 2025." He also reported progress on the ...